Enterprise Value to EBITDA Multiple ratio Analysis of Cardio Diagnostics HLDG WT - Deep Dive
Latest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-0.0014
Period Ending - Dec-22
Excellent EV to EBITDA
0.605
Growth
-100.24 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
0
EV to EBITDA Analysis of Cardio Diagnostics HLDG WT
EV to EBITDA Ratio of CDIOW drastically fell by -100.24 % this year. |
Other EV to EBITDA Related Info of CDIOW that may interest you.
Cardio Diagnostics HLDG WT Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CDIOW | 0.0551 | 0.07 | 21.29 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..EV to EBITDA Related Ratios
EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Enterprise Value to EBITDA Multiple of Cardio Diagnostics HLDG WT
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
---|---|---|---|---|
EV to EBITDA | -0.0014 | 0.605 | -0.0190 | -0.480 |
Change | -100.24 % | 3283.64 % | 96.04 % |
FY Chart of Enterprise Value to EBITDA Multiple of Cardio Diagnostics HLDG WT
Note : All Data Generated at the End of Trading Hours (EOD Data)